1 / 32

The changing pattern of viral hepatitis in Saudi Arabia

The changing pattern of viral hepatitis in Saudi Arabia. Yousef Qari, MD, FRCP(C), ABIM Gastoenterologist King Abdulaziz University Hospital. Epidemiology of Hep B Worldwide. 2 billion people are infected with this virus 350 million Chronic HBV infection.

vin
Download Presentation

The changing pattern of viral hepatitis in Saudi Arabia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The changing pattern of viral hepatitis in Saudi Arabia Yousef Qari, MD, FRCP(C), ABIM Gastoenterologist King Abdulaziz University Hospital

  2. Epidemiology of Hep B Worldwide • 2 billion people are infected with this virus • 350 million Chronic HBV infection. • 10th leading cause of death in the world

  3. Route of Transmission of HepB • High endemicity • Perinatal (vertical) • Acquired in preschool years. • Low endemicity • Early adult life • Intravenous drug use • Unprotected sexual activities

  4. The prevalence of HBsAg and other markers of HBV among residents of Jizan Ayoola AE Saudi Med J.  2003; 24(9):991-5

  5. Prevalence of HBV, HCV among blood donors in a teaching hospital in the Central region of Saudi Arabia. 24000 patients El-Hazmi MMSaudi Med J.  2004; 25(1):26-33

  6. HBV and HCV prevalence among dialysis patients in Bahrain and Saudi Arabia Qadi AA Am J Infect Control.  2004; 32(8):493-5 (ISSN: 0196-6553)

  7. Prevalence of hepatitis C virus among Bilharziasis patients in Eastern Saudi arbia Khan ZA Saudi Med J.  2004; 25(2):204-6

  8. Worled Prevalence of Hep B

  9. The decline of hepatitis B viral infection in South-Western Saudi Arabia. Ayoola AE Saudi Med J.  2003; 24(9):991-5

  10. Hepatitis C virus Seroprevalence rate among Saudis Shobokshi OA . Saudi Med J.  2003; 24 Suppl 2:S81-6

  11. Worled Prevalence of Hep C

  12. Pattern of liver diseases at a University Hospital in Western Saudi Arabia. Mansoor I. Saudi Med J.  2002; 23(9):1070-3

  13. Overview of Epidemiology of viral Hepatitis in Saudi Arabia • The prevalence rate is high in Saudi Arabia. • HBV 8%-10% • HCV 2%-6% • Age distribution: • HAV, is mainly a disease of the young • HBV, a disease of adolescents and adults • HCV, a disease of the elderly. • Male: Female ratio: • Equal in HAV and HCV • More males were affected with HBV than females. Memish Z Mil Med.  2003; 168(7):565-8

  14. The natural history of HCV infection cont‘d. • Factors that contribute to the chronicity • Male gender • Age • Alcohol intake, and • The degree of liver fibrosis on initial biopsy. • Extrahepatic complication (EHC). • 38% will have at least one EHC • The most important EHC is mixed cryoglobulinemia.

  15. Natural History of Hep C

  16. The natural history of HCV infection in Saudi Arabia. Similer pattern was noted for the rate of progression to cirrhosis and HCC Al-Quaiz MN Saudi Med J.  2003; 24 Suppl 2:S67-70

  17. Natural History of Hep C HBV Infection 15-40% HBV Chronic Hepatitis Cirrhosis HCC

  18. Hepatocellular carcinoma in Saudi Arabia: Role of hepatitis B infection. 1.9 per 1000 (2.3 in men, 1.2 in women). N=118 N=118 Ayoola EA J Gastroenterol Hepatol.  2004; 19(6):665-9

  19. The prevalence of hepatitis B core antibody positivity in donors for liver transplantation in Saudi Arabia. Non-Saudi (41.3%) Saudi nationals (16.7%). Al-Sebayel MI . Saudi Med J.  2002; 23(3):298-300

  20. The challenge of finding donors for living donor liver transplantation in Saudi Arabia. Khalaf H Transplant Proc.  2004; 36(8):2222-3

  21. Hepatitis C genotypes/subtypes among chronic hepatitis patients in Saudi Arabia • Shobokshi OASaudi Med J.  2003; 24 Suppl 2:S87-91 • Al-Traif ISaudi Med J.  2004; 25(12):1935-8

  22. Chronic hepatitis C. Genotypes and response to anti-viral therapy among Saudi patients. Al-Traif ISaudi Med J.  2004; 25(12):1935-8

  23. Peg IF + Ribavirin compared with IF + Ribavirin for initial treatment of Ch. HCV in Saudi patients with genotype 4. • 96 patients with chronic HCV • End of treatment (48 weeks) • Sustained (72 weeks) Alfaleh FZ Liver Int.  2004; 24(6):568-74

  24. Conclusion • The most prevalent genotype in the Kingdom of Saudi Arabia is • genotype 4 • genotypes 1a and 1b. • Genotype 5 was identified exclusively in the Western province and nowhere else. • Genotypes 2a,/2b, 3 and 6 are very rare in the Kingdom of Saudi Arabia.

  25. Conclusion • 86% of Saudi chronic hepatitis C cases are due to genotypes 1 and 4. • The low prevalence of HBsAg in children, provides evidence for the effectiveness and efficacy of the integration of hepatitis B vaccination into the extended program of immunization in KSA. • The significant decline of HBV markers among unvaccinated Saudi adults indicated an indirect effect of other factors like health education and socio-economic progress

  26. Conclusion • Hepatitis B virus constitutes a major risk factor and HCV contributes a less significant role in the development of HCC. • The ongoing program of HBV vaccination may significantly decrease the prevalence of HBV-associated HCC in Saudi Arabia • The present public health schemes have been effective in reducing hepatitis C infection in the general community in the Kingdom of Saudi Arabia but the infection among high risk groups remain a major problem that needs to be actively addressed.

  27. Conclusion • In Saudi Arabia, donor availability as well as recipient characteristics may limit the value of LDLT in overcoming organ shortage. Therefore, efforts should be directed to improve the number and quality of available cadaveric organs. Until then, LDLT may be the only way forward to save patients from dying on the waiting list.

  28. Thankyou Omrah Mubarakah Inshaallah

  29. Hepatitis E virus infection in haemodialysis patients: a case-control study in Saudi Arabia. 83 Saudi patients on chronic haemodialysis Ayoola EAJ Med Virol.  2002; 66(3):329-34

  30. Treatment of patients with HCV with normal liver enzymes in a Saudi population. Both groups treated with: IF 3mu thrice / w + Ribavirin Akbar HOSaudi Med J.  2002; 23(3):301-4

  31. The natural history of HCV infection. • The natural history of HCV infection is not fully understood. • Early studies of natural history reflected the more severe end of the spectrum of the disease.

More Related